サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565660

経口抗ウイルス薬市場：タイプ別、投与経路別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Oral Antiviral Market, By Type, By Route of Administration, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 316 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
経口抗ウイルス薬市場：タイプ別、投与経路別、用途別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年09月04日
発行: AnalystView Market Insights
ページ情報: 英文 316 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

経口抗ウイルス薬市場規模は2023年に379億432万米ドルとなり、2024年から2032年にかけてCAGR 2.90%で拡大

経口抗ウイルス薬市場-市場力学

ウイルス性疾患の有病率の増加が経口抗ウイルス薬市場の成長を促進

ウイルス性疾患の有病率の増加が経口抗ウイルス薬市場の成長を大きく後押ししています。世界保健機関（WHO）によると、インフルエンザとCOVID-19は依然として世界の健康上の大きな懸念であり、毎年数百万人が罹患しています。米国疾病管理予防センター（CDC）は、COVID-19パンデミックの際に抗ウイルス剤の処方が急増したことを報告し、広範な感染症の管理における経口抗ウイルス剤の重要な役割を強調しています。例えば、COVID-19の経口抗ウイルス薬であるパクスロビッドは、発売初年度に50万人以上の患者に処方されました。さらに、単純ヘルペスなどの慢性ウイルス性疾患の増加により、効果的な経口治療薬への需要が高まっています。世界的にウイルス性疾患への対策が強化される中、抗ウイルス薬の市場開拓が進み、これらの医薬品へのアクセスが拡大することは、市場成長を促進する重要な要因となっています。

経口抗ウイルス薬市場-主要洞察

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約2.90%のCAGRで毎年成長すると推定されます。

市場セグメンテーションでは、ヌクレオシド類似体が2023年に最大市場シェアを示すと予測されています。

投与経路別では、2023年に錠剤が主要タイプに

用途別では、2023年にはCOVID-19が主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

経口抗ウイルス薬市場-セグメンテーション分析：

世界の経口抗ウイルス薬市場は、タイプ、投与経路、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場はタイプによって4つのカテゴリーに分けられる：ヌクレオシド類似体、プロテアーゼ阻害剤、ノイラミニダーゼ阻害剤、ポリメラーゼ阻害剤です。ヌクレオシド類似体は、さまざまなウイルス感染症に対して幅広い効果を発揮するため、市場をリードしています。プロテアーゼ阻害剤は、特定のウイルスに標的を定めて作用します。ノイラミニダーゼ阻害剤はインフルエンザ治療において重要であり、ポリメラーゼ阻害剤は重要であるがあまり使用されていないです。

市場は投与経路によって3つのカテゴリーに分けられる：錠剤、カプセル剤、経口懸濁剤です。錠剤は、その利便性と投与量の正確さから最も人気のある投与経路です。カプセルはその後に続き、異なる剤形でありながら同様の利点を提供しています。経口懸濁液の使用頻度は低いが、錠剤やカプセルの嚥下が困難な患者にとっては貴重な存在です。

経口抗ウイルス剤市場-地理的洞察

経口抗ウイルス薬市場には地域差があり、北米が先進ヘルスケアシステムと高い薬剤採用率でリードしています。米国では、COVID-19の大流行時にFDAがパクスロビッドのような経口抗ウイルス薬を迅速に承認したため、初年度に1,000万回以上の投与が行われ、広く使用されるようになった。英国やドイツなどの国々が包括的な抗ウイルス治療プログラムを実施し、市場の需要を大幅に増加させています。欧州医薬品庁（EMA）は、新しい抗ウイルス薬の承認を迅速に行うことで、この成長を支えています。アジア太平洋地域では、ウイルス感染率の上昇とヘルスケア投資の増加により、日本やインドなどの国々が急速な市場拡大を経験しています。例えば、日本の厚生省はインフルエンザの流行管理に経口抗ウイルス薬の使用を推進しています。また、ラテンアメリカや中東・アフリカも、ヘルスケアインフラの増加や抗ウイルス治療に対する意識の高まりによって成長市場となっています。

経口抗ウイルス薬市場-競合情勢：

経口抗ウイルス薬市場は競争市場であり、大手企業は市場での地位を維持するために戦略的な取り組みを積極的に行っています。大手企業であるファイザーは、COVID-19治療薬パクスロビドを発売し、低所得国における抗ウイルス治療へのアクセスを拡大するため、2022年にビル&メリンダ・ゲイツ財団と提携しました。メルク社はCOVID-19治療薬モルヌピラビルで注目を集め、2021年にはリッジバック・バイオセラピューティクス社と提携し、開発と流通を加速させました。ベクリュリー（レムデシビル）で知られるギリアド・サイエンシズは、抗ウイルスポートフォリオの革新と拡大を続けています。さらに、ロシュ・ホールディングスは2023年に抗ウイルス剤のTIBモルビオールを買収し、ウイルス診断と治療における地位を強化しています。これらの企業は、パートナーシップ、買収、提携を活用して抗ウイルス剤の提供を強化し、効果的な経口抗ウイルス療法に対する世界の需要の高まりに対応しています。

目次

第1章 経口抗ウイルス薬市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 経口抗ウイルス薬の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 経口抗ウイルス薬産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 経口抗ウイルス薬市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 経口抗ウイルス薬市場情勢

  • 経口抗ウイルス薬の市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 経口抗ウイルス薬市場- タイプ別

  • 概要
    • セグメントシェア分析
    • ヌクレオシド類似体
    • プロテアーゼ阻害剤
    • ノイラミニダーゼ阻害剤
    • ポリメラーゼ阻害剤

第8章 経口抗ウイルス薬市場- 投与経路別

  • 概要
    • セグメントシェア分析
    • 錠剤
    • カプセル
    • 経口懸濁液

第9章 経口抗ウイルス薬市場- 用途別

  • 概要
    • セグメントシェア分析
    • HIV
    • 肝炎
    • インフルエンザ
    • COVID-19
    • ヘルペス

第10章 経口抗ウイルス薬市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 病院
    • クリニック
    • 在宅ケア環境
    • 薬局

第11章 経口抗ウイルス薬市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 経口抗ウイルス薬業界

  • 競争ダッシュボード
  • 企業プロファイル
    • AbbVie Inc.
    • Amgen Inc.
    • Aurobindo Pharma Limited
    • BioCryst Pharmaceuticals, Inc.
    • Bristol-Myers Squibb Company
    • Cipla Limited
    • Dr. Reddy's Laboratories Ltd.
    • Gilead Sciences, Inc.
    • GlaxoSmithKline plc
    • Johnson &Johnson Services, Inc.
    • Merck &Co., Inc.
    • Mylan NV（part of Viatris Inc.）
    • Novartis International AG
    • Pfizer Inc.
    • Roche Holding AG
    • Teva Pharmaceutical Industries Ltd.
    • Others

第13章 アナリストの全方位展望

目次
Product Code: ANV3856

REPORT HIGHLIGHT

Oral Antiviral Market size was valued at USD 37,904.32 Million in 2023, expanding at a CAGR of 2.90% from 2024 to 2032.

The Oral Antiviral Market focuses on medications taken by mouth to treat viral infections, providing an accessible and convenient option for patients. The market is experiencing growth due to the increasing prevalence of viral diseases such as influenza, COVID-19, and herpes simplex. For example, the global market saw a notable rise in oral antiviral treatments with the approval of Paxlovid in 2021, which has been widely utilized for COVID-19 management. However, challenges such as high drug costs and concerns about long-term resistance can impede market growth. Opportunities lie in the development of next-generation oral antivirals with broader efficacy and lower resistance profiles. Additionally, the rising emphasis on personalized medicine and the expansion of healthcare access in emerging markets are contributing to the growth of oral antiviral therapies. The growing number of antiviral drugs in the pipeline and increasing investment in research and development further underscore the market's potential.

Oral Antiviral Market- Market Dynamics

Increasing Prevalence of Viral Diseases Boosts Growth in Oral Antiviral Market

The increasing prevalence of viral diseases is significantly driving the growth of the Oral Antiviral Market. According to the World Health Organization (WHO), influenza and COVID-19 remain major global health concerns, with millions affected annually. The U.S. Centers for Disease Control and Prevention (CDC) reported a surge in antiviral prescriptions during the COVID-19 pandemic, highlighting the critical role of oral antivirals in managing widespread infections. For instance, Paxlovid, an oral antiviral for COVID-19, was prescribed to over 500,000 patients in its first year of availability. Additionally, the rise in chronic viral conditions, such as herpes simplex, has increased the demand for effective oral treatments. As the global focus on combating viral diseases intensifies, advancements in antiviral drug development and expanding access to these medications are crucial factors driving market growth.

Oral Antiviral Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.90% over the forecast period (2024-2032)

Based on Type segmentation, Nucleoside Analogues were predicted to show maximum market share in the year 2023

Based on Route of Administration segmentation, Tablets was the leading type in 2023

Based on Application segmentation, COVID-19 was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Oral Antiviral Market- Segmentation Analysis:

The Global Oral Antiviral Market is segmented on the basis of Type, Route of Administration, Application, End-User, and Region.

The market is divided into four categories based on Type: Nucleoside Analogues, Protease Inhibitors, Neuraminidase Inhibitors, and Polymerase Inhibitors. Nucleoside analogues lead the market due to their broad efficacy against various viral infections. Protease inhibitors follow, offering targeted action against specific viruses. Neuraminidase inhibitors are significant for influenza treatment, while polymerase inhibitors are crucial but less commonly used.

The market is divided into three categories based on Route of Administration: Tablets, Capsules, and Oral Suspensions. Tablets are the most popular route of administration due to their convenience and dosage accuracy. Capsules follow closely, offering similar benefits with a different format. Oral suspensions are used less frequently but are valuable for patients who have difficulty swallowing tablets or capsules.

Oral Antiviral Market- Geographical Insights

The Oral Antiviral Market shows distinct regional variations, with North America leading due to advanced healthcare systems and high drug adoption rates. In the U.S., the FDA's rapid approval of oral antivirals like Paxlovid during the COVID-19 pandemic led to widespread use, with over 10 million doses administered in the first year. Europe follows closely, where countries such as the UK and Germany have implemented comprehensive antiviral treatment programs, significantly increasing market demand. The European Medicines Agency (EMA) has supported this growth by fast-tracking approvals for new antiviral drugs. In the Asia-Pacific region, countries like Japan and India are experiencing rapid market expansion due to rising viral infection rates and increased healthcare investments. For instance, Japan's Ministry of Health has promoted the use of oral antivirals in managing influenza outbreaks. Latin America and the Middle East & Africa are also growing markets, driven by increasing healthcare infrastructure and rising awareness of antiviral treatments.

Oral Antiviral Market- Competitive Landscape:

The Oral Antiviral Market is competitive, with major players actively engaging in strategic initiatives to maintain their market positions. Pfizer, a leading player, launched Paxlovid for COVID-19 and partnered with the Bill & Melinda Gates Foundation in 2022 to expand access to antiviral treatments in low-income countries. Merck & Co. has made headlines with its Molnupiravir for COVID-19, and in 2021, it collaborated with Ridgeback Biotherapeutics to accelerate its development and distribution. Gilead Sciences, known for Veklury (remdesivir), has continued to innovate and expand its antiviral portfolio. Additionally, Roche Holdings acquired the antiviral company TIB Molbiol in 2023 to strengthen its position in viral diagnostics and treatments. These companies are leveraging partnerships, acquisitions, and collaborations to enhance their antiviral offerings and address the growing global demand for effective oral antiviral therapies.

Recent Developments:

In November 2021, Pfizer's investigational COVID-19 oral antiviral, PAXLOVID(TM), demonstrated an 89% reduction in hospitalization or death risk in high-risk adults during a Phase 2/3 study. The company plans to submit data to the FDA for Emergency Use Authorization soon.

In October 2021, Merck and Ridgeback Biotherapeutics announced that their investigational oral antiviral, molnupiravir, reduced the risk of hospitalization or death by about 50% in mild to moderate COVID-19 patients. They plan to seek Emergency Use Authorization from the FDA based on these results.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ORAL ANTIVIRAL MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • AbbVie Inc.
  • Amgen Inc.
  • Aurobindo Pharma Limited
  • BioCryst Pharmaceuticals, Inc.
  • Bristol-Myers Squibb Company
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Mylan N.V. (part of Viatris Inc.)
  • Novartis International AG
  • Pfizer Inc.
  • Roche Holding AG
  • Teva Pharmaceutical Industries Ltd.
  • Others

GLOBAL ORAL ANTIVIRAL MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Nucleoside Analogues
  • Protease Inhibitors
  • Neuraminidase Inhibitors
  • Polymerase Inhibitors

GLOBAL ORAL ANTIVIRAL MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Tablets
  • Capsules
  • Oral Suspensions

GLOBAL ORAL ANTIVIRAL MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • HIV
  • Hepatitis
  • Influenza
  • COVID-19
  • Herpes

GLOBAL ORAL ANTIVIRAL MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Homecare Settings
  • Pharmacies

GLOBAL ORAL ANTIVIRAL MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Oral Antiviral Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Oral Antiviral Market Snippet by Type
    • 2.1.2. Oral Antiviral Market Snippet by Route of Administration
    • 2.1.3. Oral Antiviral Market Snippet by Application
    • 2.1.4. Oral Antiviral Market Snippet by End-User
    • 2.1.5. Oral Antiviral Market Snippet by Country
    • 2.1.6. Oral Antiviral Market Snippet by Region
  • 2.2. Competitive Insights

3. Oral Antiviral Key Market Trends

  • 3.1. Oral Antiviral Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Oral Antiviral Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Oral Antiviral Market Opportunities
  • 3.4. Oral Antiviral Market Future Trends

4. Oral Antiviral Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Oral Antiviral Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Oral Antiviral Market Landscape

  • 6.1. Oral Antiviral Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Oral Antiviral Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Nucleoside Analogues
    • 7.1.3. Protease Inhibitors
    • 7.1.4. Neuraminidase Inhibitors
    • 7.1.5. Polymerase Inhibitors

8. Oral Antiviral Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 8.1.2. Tablets
    • 8.1.3. Capsules
    • 8.1.4. Oral Suspensions

9. Oral Antiviral Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. HIV
    • 9.1.3. Hepatitis
    • 9.1.4. Influenza
    • 9.1.5. COVID-19
    • 9.1.6. Herpes

10. Oral Antiviral Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Homecare Settings
    • 10.1.5. Pharmacies

11. Oral Antiviral Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Oral Antiviral Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Oral Antiviral Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Oral Antiviral Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Oral Antiviral Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Oral Antiviral Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Oral Antiviral Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. AbbVie Inc.
    • 12.2.2. Amgen Inc.
    • 12.2.3. Aurobindo Pharma Limited
    • 12.2.4. BioCryst Pharmaceuticals, Inc.
    • 12.2.5. Bristol-Myers Squibb Company
    • 12.2.6. Cipla Limited
    • 12.2.7. Dr. Reddy's Laboratories Ltd.
    • 12.2.8. Gilead Sciences, Inc.
    • 12.2.9. GlaxoSmithKline plc
    • 12.2.10. Johnson & Johnson Services, Inc.
    • 12.2.11. Merck & Co., Inc.
    • 12.2.12. Mylan N.V. (part of Viatris Inc.)
    • 12.2.13. Novartis International AG
    • 12.2.14. Pfizer Inc.
    • 12.2.15. Roche Holding AG
    • 12.2.16. Teva Pharmaceutical Industries Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us